Screener
Eli Lilly LLY Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Eli Lilly’s reported figures.
Based on trailing twelve months.
The source filing: Eli Lilly’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 11:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000059478-26-000045
FAQ
- What is Eli Lilly's return on equity?
- Eli Lilly (LLY) reported return on equity of 107.6% in Q1 2026.
- How has Eli Lilly's return on equity changed year-over-year?
- Eli Lilly's return on equity increased by 38.5% year-over-year, from 77.7% to 107.6%.
- What is the long-term trend for Eli Lilly's return on equity?
- Over 5 years (2020 to 2025), Eli Lilly's return on equity has grown at a -7.6% compound annual growth rate (CAGR), from 150.2% to 101.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Eli Lilly's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude